NCT02321865View on ClinicalTrials.gov

Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency

PHASE3CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 21, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 24, 2015

Conditions
Zinc Deficiency
Interventions
DRUG

NPC-02

Trial Locations (1)

537-8511

Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka

Sponsors

Lead Sponsor

Nobelpharma
All Listed Sponsors
lead

Nobelpharma

INDUSTRY

NCT02321865 - Dose Adjustment Study of NPC-02 in Patients With Zinc Deficiency | Biotech Hunter | Biotech Hunter